Venture Certified
| 기술평가보증기업(기금) | 2020-01-08 ~ 2022-01-07 | 20200100193 | 2020-01-08 |
| 혁신성장유형 | 2022-01-08 ~ 2025-01-07 | 20211229030068 | 2020-01-08 |
| 혁신성장유형 | 2025-09-23 ~ 2028-09-22 | 20250923030018 | 2020-01-08 |
Revenue CAGR +7.8%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 255B | 244B | 220B |
| Operating Profit | -4.9B | 0.7B | 8.1B |
| Net Profit | -17B | -9.3B | 3.1B |
| Total Assets | 426B | 411B | 317B |
| Total Liabilities | 312B | 283B | 186B |
| Total Equity | 114B | 129B | 131B |
Operating Loss: Op. profit -5B
2 Consecutive Years of Net Loss
▲ 10.1%
▼ 210.7%
▼ 196.1%
▲ 50.5%
▼ 521.3%
| Name | Position | Role |
|---|---|---|
| 구성민 | 대표이사 | 대표 |
| Patent Title | Applicant | Application No. | Filing Date | Status |
|---|---|---|---|---|
| 천연물을 포함하는 대사성 질환의 개선, 예방 또는 치료용 조성물 | (주)옥천당 | 1020240037554 | 2024-03-19 | 공개 |
| 황기와 산초 추출물을 유효성분으로 포함하는 면역증진용 복합 조성물 | (주)옥천당 | 1020230177052 | 2023-12-07 | 공개 |
| 보리수나무 열매 추출물을 포함하는 여성 갱년기 증상 예방, 치료 및 개선용 조성물 | (주)옥천당 | 1020230124593 | 2023-09-19 | 공개 |
| 천연 추출물을 포함하는 인플루엔자바이러스 또는 코로나바이러스에 대한 항바이러스용 조성물 | (주)옥천당 | 1020230116223 | 2023-09-01 | 등록 |
| 항암제 투여시 유발되는 소화관 장애의 효과적 제어가 가능한 신규 조성물 | (주)옥천당 | 1020230115963 | 2023-09-01 | 등록 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "대구광역시 동구",
"ceo_name": "구성민",
"certificate": [
{
"cert_number": "20200100193",
"changes": "",
"disclosure_date": "2020-01-08",
"first_cert_date": "2020-01-08",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2020-01-08 ~ 2022-01-07"
},
{
"cert_number": "20211229030068",
"changes": "",
"disclosure_date": "2021-12-29",
"first_cert_date": "2020-01-08",
"no": "2",
"type": "혁신성장유형",
"valid_period": "2022-01-08 ~ 2025-01-07"
},
{
"cert_number": "20250923030018",
"changes": "",
"disclosure_date": "2025-09-23",
"first_cert_date": "2020-01-08",
"no": "3",
"type": "혁신성장유형",
"valid_period": "2025-09-23 ~ 2028-09-22"
}
],
"company_name": "㈜옥천당",
"corp_no": "230111-*******",
"financials": {
"2022": {
"capital_stock": 2313467000,
"cost_of_sales": 15657841000,
"current_assets": 18826270000,
"current_liabilities": 16675933000,
"gross_profit": 6306002000,
"net_income": 312602000,
"net_income_bs": 625853000,
"non_current_assets": 12883828000,
"non_current_liabilities": 1938569000,
"non_operating_expenses": 587911000,
"non_operating_income": 94442000,
"operating_profit": 806071000,
"revenue": 21963844000,
"sga_expenses": 5499931000,
"total_assets": 31710098000,
"total_equity": 13095596000,
"total_liabilities": 18614502000
},
"2023": {
"capital_stock": 2313467000,
"cost_of_sales": 17918721000,
"current_assets": 17010758000,
"current_liabilities": 19515473000,
"gross_profit": 6464147000,
"net_income": -934533000,
"net_income_bs": -253448000,
"non_current_assets": 24137034000,
"non_current_liabilities": 8771124000,
"non_operating_expenses": 1031141000,
"non_operating_income": 23269000,
"operating_profit": 73339000,
"revenue": 24382868000,
"sga_expenses": 6390808000,
"total_assets": 41147792000,
"total_equity": 12861196000,
"total_liabilities": 28286597000
},
"2024": {
"capital_stock": 2313467000,
"cost_of_sales": 18851745000,
"current_assets": 18254235000,
"current_liabilities": 30625482000,
"gross_profit": 6652575000,
"net_income": -1735103000,
"net_income_bs": -1432966000,
"non_current_assets": 24377496000,
"non_current_liabilities": 559117000,
"non_operating_expenses": 1307208000,
"non_operating_income": 58734000,
"operating_profit": -486629000,
"revenue": 25504320000,
"sga_expenses": 7139204000,
"total_assets": 42631731000,
"total_equity": 11447133000,
"total_liabilities": 31184599000
}
},
"industry": "한의약품 제조업",
"investment": [],
"main_products": "한의약품 규격한약재 등",
"phone": "053-950-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Employment Insurance | 2026-02-25 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |